Connect with us

Health

NetworkNewsWire Issues Article On Lexaria Bioscience Corp (OTCMKTS:LXRP)

Published

on

NetworkNewsWire or also known as “NNW” posted about a publication of an editorial showcasing Lexaria Bioscience Corp (OTCMKTS:LXRP), a client of NNW. The publication reviews solutions by numerous public firms, including tobacco industry pioneers, intended to assist deliver nicotine without the damaging smoke of cigarettes.

The buzz

Lexaria has its research focus on nicotine after its patent grant and is working on formulations of edible types of nicotine utilizing the DehydraTECH™ know-how. These formulations are presently completing quality control check prior to in tolerability testing and vivo absorption. A third-party lab is anticipated to conduct the first nicotine edible checks in February 2018.

Consider an edible nicotine-infused offering that masks unwanted tastes, removing the requirement for sugar-filled edibles; lowers the onset time with effects experienced within 15 to 20 minutes instead of up to one hour or more; averts first-pass liver metabolism, which indicates fewer side effects; and enhances bio-absorption by 5 to 10 times, all while helping user quit smoking cigarettes.

Lexaria’s proprietary platform enables for the infusion of nicotine molecules within an extensive range of typical capsule formats or edible food ingredients, effectively paving the door for the establishment of a new product segment targeting the buzzing smoking cessation market. While this research remains in its preliminary stages, the market implications of enhancing company’s patented molecular delivery way in such segments as nicotine delivery, vitamins and non-steroidal anti-inflammatories is significant.

As per a 2016 report posted by Grand View Research, Inc., the international nicotine de-addiction and smoking cessation market is anticipated to reach more than $21.8 billion by 2024. The launch of innovative and improved nicotine replacement therapy offerings is to serve as a major impact rendering factor for the growth of the nicotine de-addiction and smoking cessation market.

In the last trading session, the shares price of Lexaria Bioscience dropped around 9% to close the day at $1.77.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement